Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Pediatric Epilepsy
Interventions
DRUG

Depakote Delayed-Release/Depakote Sprinkle

Administered according to the subject's usual regimen.

DRUG

Depakote ER

Dose converted to 8-20% higher than Depakote DR or Depakote Sprinkle.

Trial Locations (1)

23284

Richmond

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00646711 - Pediatric Switch Study for Children and Adolescent Patients With Epilepsy | Biotech Hunter | Biotech Hunter